financetom
Business
financetom
/
Business
/
Elevation Gold Mining Provides Update on Claim Filed by Patriot Gold; Down Nearly 6%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elevation Gold Mining Provides Update on Claim Filed by Patriot Gold; Down Nearly 6%
Apr 12, 2024 9:37 AM

12:08 PM EDT, 04/12/2024 (MT Newswires) -- Elevation Gold Mining ( EVGDF ) on Friday provided an update on a claim filed by Patriot Gold in the Arizona State Superior Court.

The claim was filed after the company earlier this month temporarily halted its royalty/finder fee payments and silver stream delivery obligations because of lower-than-expected production to preserve sufficient liquidity for the continued operation of the Moss Mine.

The company said it is in talks with Patriot to resolve the claim without litigation.

Patriot Gold, which holds a 3% net smelter returns royalty on the Moss Mine, filed the claim for payment of amounts owed under the NSR royalty.

The company's shares were last seen down C$0.005 to C$0.08 on the TSX Venture Exchange.

Price: 0.08, Change: -0.01, Percent Change: -5.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?
What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?
Apr 2, 2024
Tuesday, Gritstone Bio Inc ( GRTS ) released preliminary data from the ongoing, signal-seeking Phase 2 portion of the Phase 2/3 study evaluating GRANITE, its personalized neoantigen cancer vaccine, in front-line metastatic microsatellite stable colorectal cancer (MSS-CRC).  The study is designed to quantify the clinical benefit of maintenance therapy with GRANITE (GRT-C901/GRT-R902) in combination with immune checkpoint blockade in addition to fluoropyrimidine/bevacizumab versus...
UL Solutions' Sole Stockholder to Offer 28 Million Shares in IPO
UL Solutions' Sole Stockholder to Offer 28 Million Shares in IPO
Apr 2, 2024
10:47 AM EDT, 04/02/2024 (MT Newswires) -- UL Solutions (ULS) said in a regulatory filing Tuesday that its sole shareholder, ULSE, plans to sell 28 million shares in an initial public offering priced at $26 to $29 per share. The selling stockholder has provided a 30-day option to underwriters to buy up to a further of 4.2 million shares, UL...
CarMax Fiscal Q4 Earnings Seen Mostly In-Line, Wedbush Says
CarMax Fiscal Q4 Earnings Seen Mostly In-Line, Wedbush Says
Apr 2, 2024
10:58 AM EDT, 04/02/2024 (MT Newswires) -- CarMax ( KMX ) is likely to report mostly in-line fiscal Q4 earnings, with upside potential later in 2024 through 2026, Wedbush Securities said in a note Tuesday. The used-vehicle retailer is scheduled to report fiscal Q4 financial results on April 11. Wedbush projects earnings at $0.40 per share, compared with market expectations...
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test
Apr 2, 2024
10:58 AM EDT, 04/02/2024 (MT Newswires) -- QuidelOrtho ( QDEL ) said Tuesday that its QuickVue COVID-19 test has received 510(k) clearance from the US Food and Drug Administration. The clearance allows the test to be used in home and medical facility settings with CLIA certificates of waiver, the company said. QuidelOrtho ( QDEL ) shares were down more than...
Copyright 2023-2026 - www.financetom.com All Rights Reserved